C

Capstan Therapeutics

61 employees

Capstan Therapeutics is advancing cell engineering to develop therapeutics for a broad range of diseases.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Therapeutics
Health Care

Date founded

2021

Funding rounds raised

Total raised

$102M

from 9 investors over 9 rounds

C

Capstan Therapeutics raised $102M on September 14, 2022

Investors: Vida Ventures, LLC, Bristol-Myers Squibb, UK, RA Capital Management, L.P., Leaps by Bayer, Polaris Partners and OrbiMed Advisors

C

Capstan Therapeutics raised $63M on November 1, 2021

Investors: OrbiMed Advisors, RA Capital Management, L.P. and Vida Ventures, LLC

FAQ